当前位置: X-MOL 学术J. Cachexia Sarcopenia Muscle › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles
Journal of Cachexia, Sarcopenia and Muscle ( IF 8.9 ) Pub Date : 2022-09-09 , DOI: 10.1002/jcsm.13079
Meng Fan 1, 2 , Xiaofan Gu 2 , Wanli Zhang 2 , Qiang Shen 1 , Ruiqin Zhang 1 , Qiaoyu Fang 1 , Yueping Wang 1 , Xiaodong Guo 3 , Xiongwen Zhang 2 , Xuan Liu 1
Affiliation  

Atractylenolide I (AI) is a natural sesquiterpene lactone isolated from Atractylodes macrocephala Koidz, known as Baizhu in traditional Chinese medicine. AI has been found to ameliorate cancer cachexia in clinic cancer patients and in tumour-bearing mice. Here, we checked the influence of AI on biogenesis of IL-6 and extracellular vesicles (EVs) in cancer cachexia mice and then focused on studying mechanisms of AI in inhibiting the production of tumour-derived EVs, which contribute to the ameliorating effects of AI on cancer cachexia.

中文翻译:

Atractylenolide I 通过抑制 IL-6 和肿瘤来源的细胞外囊泡的生物发生来改善癌症恶病质

Atractylenolide I (AI) 是从白术中分离得到的天然倍半萜内酯,中药称为白术。已发现 AI 可以改善临床癌症患者和荷瘤小鼠的癌症恶病质。在这里,我们检查了 AI 对癌症恶病质小鼠 IL-6 和细胞外囊泡 (EVs) 生物发生的影响,然后重点研究了 AI 抑制肿瘤衍生 EVs 产生的机制,这有助于 AI 的改善作用关于癌症恶病质。
更新日期:2022-09-09
down
wechat
bug